Paras Healthcare Initial Public Offering (IPO) opened for bidding today (October 21) and was subscribed to a total of 0.15 times as of Day 1. The company aims to raise Rs 1,450 crore via a combination of 72.15 lakh fresh shares amounting to Rs 500 crore, and an offer for sale of 1.37 crore shares aggregating to Rs 950 crore. The firm has set the issue price band in a range of Rs 660 to Rs 693 per equity share. The subscription window will close on October 23.
Paras Healthcare IPO: Subscription status
The issue was booked 0.15 times on Day 1, led by retail investors. The individual investor (retail) category was subscribed 0.69 times for the day. The Non-Institutional Investors (NIIs) booked the issue 0.08 times, while the Qualified Institutional Buyers were yet to jump in.
Paras Healthcare’s last recorded Grey Market Premium (GMP) was Rs 39, up 5.63 per cent from the upper price band. Based on the GMP trend, the estimated listing price for Paras Healthcare IPO is likely to be Rs 732. This hints at a gain of Rs 819 on one lot of 21 shares.
Paras Healthcare IPO: Allotment and listing
Paras Healthcare IPO: Lot size
A retail applicant needs to apply for at least one lot that contains 21 shares. The minimum amount of investment required by an individual investor is Rs 14,553.
Paras Healthcare IPO: BRLM and registrar
Expert’s take on Paras Healthcare
The company’s growth is expected to be supported by rising occupancy in newer hospitals, expansion of high-acuity specialties and planned capacity additions at Gurugram and Ludhiana.
However, the company’s high dependence on government schemes and PSU patients, coupled with regulatory and pricing-related uncertainties in the healthcare sector, remains a key monitorable, said SBICap Securities in an IPO note.
“While the company is well positioned to benefit from increasing healthcare demand in its operating regions, we assign a NEUTRAL rating to the issue and would like to track occupancy levels, execution of upcoming capacity additions and the impact of regulatory developments over the next few quarters post listing,” the brokerage house added.
Paras Healthcare is a leading clinical specialty-led hospital platform providing tertiary and quaternary healthcare services across North India, Bihar, and Jharkhand under the “Paras Health” brand.
Incorporated in1987, the company operates eight hospitals with an aggregate bed capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar as of June 30, 2026.
It specialises in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics & sports injury, and renal sciences (CONGOR specialties), which contributed 75.30% of revenue in Fiscal 2026.